SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-21-007570
Filing Date
2021-11-04
Accepted
2021-11-04 16:41:59
Documents
57
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcrx20210930_10q.htm   iXBRL 10-Q 1383752
2 EXHIBIT 10.7 ex_299565.htm EX-10.7 1197
3 EXHIBIT 10.8 ex_299566.htm EX-10.8 11283
4 EXHIBIT 10.9 ex_299567.htm EX-10.9 11244
5 EXHIBIT 10.10 ex_299598.htm EX-10.10 11257
6 EXHIBIT 31.1 ex_299568.htm EX-31.1 11979
7 EXHIBIT 31.2 ex_299569.htm EX-31.2 11878
8 EXHIBIT 32.1 ex_299570.htm EX-32.1 4401
9 EXHIBIT 32.2 ex_299571.htm EX-32.2 4390
15 exh107_1.jpg GRAPHIC 181740
16 exh107_2.jpg GRAPHIC 44666
  Complete submission text file 0001171843-21-007570.txt   6792927

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA bcrx-20210930.xsd EX-101.SCH 60291
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcrx-20210930_cal.xml EX-101.CAL 37297
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcrx-20210930_def.xml EX-101.DEF 425711
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcrx-20210930_lab.xml EX-101.LAB 407316
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcrx-20210930_pre.xml EX-101.PRE 439098
17 EXTRACTED XBRL INSTANCE DOCUMENT bcrx20210930_10q_htm.xml XML 961337
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 211380546
SIC: 2836 Biological Products, (No Diagnostic Substances)